In adults living with HIV, the 21-valent pneumococcal conjugate vaccine (PCV) V116 was well tolerated and effective against all 21 target serotypes. The immune responses were comparable to those ...

Please provide your email address to receive an email when new articles are posted on . Researchers compared the 21-valent vaccine to a combination of a 15-valent and 23-valent vaccines. Fewer adverse ...

Autumn brings a chill in the air—and the start of another season of respiratory illnesses, which can be especially hard for older adults. Although vaccine recommendations have been in flux, the ...

With vaccine sales on the decline across the industry, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. But in the third quarter, the company recorded encouraging sales ...

On January 5, 2026, under Health and Human Services Secretary Kennedy's leadership, the Centers for Disease Control and Prevention (CDC) released changes to America's longstanding vaccination ...

Experts say vaccine coverage in the U.S. is slipping, leaving more people vulnerable to preventable diseases. Measles and other once-rare infections are making a comeback as misinformation fuels ...

University of Virginia provides funding as a member of The Conversation US. Autumn brings a chill in the air – and the start of another season of respiratory illnesses, which can be especially hard ...